Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,

Slides:



Advertisements
Similar presentations
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Advertisements

Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor  Marc Riquet, MD, PhD, Antoine Legras, MD,
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,
Bronchial Carcinoid Tumors Causing Cushing's Syndrome: More Aggressive Behavior and the Need for Early Diagnosis  Guillaume Boddaert, MD, Bertrand Grand,
Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: Current Practice Patterns and Predictors of Adoption  Justin D. Blasberg, MD, Christopher W. Seder,
Constantin Stefanidis, MD, Albert M
Is the Rate of Pneumonectomy Higher in Right Middle Lobe Lung Cancer Than in Other Right-Sided Locations?  Caroline Rivera, MD, Pierre Mordant, MD, PhD,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor  Marc Riquet, MD, PhD, Antoine Legras, MD,
Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer  Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
The Annals of Thoracic Surgery
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Postoperative Pneumonia After Major Pulmonary Resections: An Unsolved Problem in Thoracic Surgery  Dana M. Radu, MD, Françoise Jauréguy, Pharm D, Agathe.
Operative Results and Outcomes in Children With Shone's Anomaly
Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K
Eduardo Crema, PhD, MD, Lara B. P. Ribeiro, Juverson A. Terra, Alex A
Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival  Daniel L. Miller, MD, William R. Mayfield, MD,
Simultaneous Lung and Spine Impalement From a Fractured Humerus After Blunt Trauma  Françoise Le Pimpec-Barthes, MD, PhD, Davy Ngabou, MD, Thierry Della-Siega,
Demographic, Psychosocial, and Behavioral Factors Associated With Survival After Heart Transplantation  Steven A. Farmer, MD, PhD, Kathleen L. Grady,
Pleural Metastasis of Osteosarcoma
Lung Cancer Surgery in Patients With Liver Cirrhosis
Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R
Lung Cancer and Its Operable Brain Metastasis: Survival Rate and Staging Problems  József Furák, MD, PhD, Imre Troján, MD, Tamás Szöke, MD, László Agócs,
Who Do You Say You Are? The Annals of Thoracic Surgery
Use of Amiodarone After Major Lung Resection
Abel Gómez-Caro, MD, Pedro Arguis, MD  The Annals of Thoracic Surgery 
Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer  Lisa M. Brown, MD, Brian.
Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer  Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,
Solitary Fibrous Tumors of the Pleura: A Poorly Defined Malignancy Profile  Guillaume Boddaert, MD, Patrice Guiraudet, MD, Bertrand Grand, MD, Nicolas.
Pulmonary Resection for Lung Cancer in Octogenarians
Gerald G.R. Sng, Cameron D. Wright, MD  The Annals of Thoracic Surgery 
Intrathoracic Lymph Node Metastases From Extrathoracic Carcinoma: The Place for Surgery  Marc Riquet, MD, Pascal Berna, MD, Emmanuel Brian, MD, Alain.
The Annals of Thoracic Surgery
Renal Cell Carcinoma Lung Metastases Surgery: Pathologic Findings and Prognostic Factors  Jalal Assouad, MD, Boriana Petkova, MD, Pascal Berna, MD, Antoine.
Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung  Marc Riquet, MD, Dominique Manac’h, MD, Françoise Le.
Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty
Acute Aortic Valve Thrombosis Secondary to Recombinant Factor VIIa
Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis  Shun-ichi Watanabe, MD, Kenji Suzuki,
Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence  Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,
Editorial Board, January 2010
Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival  Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,
Severe Two-Vessel Ostial Stenosis of the Main Coronary Arteries in a Patient With Transposition of the Great Arteries After an Arterial Switch Operation 
Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor
Surgical Treatment of Aortic Prosthetic Valve Endocarditis: A 20-Year Single-Center Experience  Sossio Perrotta, MD, Anders Jeppsson, MD, PhD, Victoria.
Chylous reflux into localized pulmonary lymphangiectasis
The Annals of Thoracic Surgery
David P. Mason, MD, Chase R. Brown, BS, Sudish C
Does Timing of Surgical Procedure After Neoadjuvant Chemoradiation Affect Outcomes in Esophageal Cancer?  Williams Tessier, MD, Caroline Gronnier, MD,
Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer  Pamela Samson, MD,
Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F
Prognostic Factors and Surgical Indications of Pulmonary Epithelioid Hemangioendothelioma: A Review of the Literature  Patrick Bagan, MD, Mohammed Hassan,
Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases  Yukinori.
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients  Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,
“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:
Posttraumatic Main Left Bronchial Rupture
Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study  Robert J. Cerfolio, MD, Ayesha.
Mark I. Block, MD  The Annals of Thoracic Surgery 
Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases  Marc Riquet, MD, PhD, Patrick Bagan,
Late Consequences of a Much Earlier Decision
Lobectomy Versus Limited Resection in T1N0 Lung Cancer
The Impact of New Technology on Cardiothoracic Surgical Practice
Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support  Peter B. Manning, MD, Michael J. Rutter, MD,
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Lung Cancer Invading the Pericardium: Quantum of Lymph Nodes
J. Alberto Lopez, MD  The Annals of Thoracic Surgery 
Presentation transcript:

Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame, MD, Christophe Foucault, MD, Antoine Dujon, MD, Françoise Le Pimpec Barthes, MD, PhD, Marc Riquet, MD, PhD  The Annals of Thoracic Surgery  Volume 97, Issue 4, Pages 1156-1162 (April 2014) DOI: 10.1016/j.athoracsur.2013.12.047 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Schematic representation of the different patterns of lymphatic spread from the right lung: (A) pN0N2-1S; (B) pN1N2-1S; (C) pN0N2-2S; and (D) pN1N2-2S. The Annals of Thoracic Surgery 2014 97, 1156-1162DOI: (10.1016/j.athoracsur.2013.12.047) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Long-term survival according to the cN status: cN0 (n = 238) median 30 months, 5-year 32%; cN1 (n = 96) median 19 months, 5-year 20.3%; cN2 (n = 537) median 21 months, 5-year 22.7% (p = 0.0015). The Annals of Thoracic Surgery 2014 97, 1156-1162DOI: (10.1016/j.athoracsur.2013.12.047) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Long-term survival according to the pN status and the type of pN2 involvement. (A) Long-term survival of pN0, pN1, and pN2 patients. pN0 (n = 2,317) median 80 months, 5-year 58.6%, 10-year 37.3%. pN1 (n = 722) median 48 months, 5-year 45.1%, 10-year 26.8%. pN2 (n = 871) median 23 months, 5-year 25.4%, 10-year 17% (p < 0.001). (B) Long-term survival of pN2-1S and pN2-2S. pN2-1S (n = 575) median 26 months, 5-year 29.8%, 10-year 20.6%. pN2-2S (n = 296) median 16 months, 5-year 16.8%, 10-year 9.7% (p < 0.001). (C) Long-term survival of pN0N2-1S, pN0N2-2S, pN1N2-1S, pN1N2-2S patients (p < 0.001). The Annals of Thoracic Surgery 2014 97, 1156-1162DOI: (10.1016/j.athoracsur.2013.12.047) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions